Article
Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin.
Annals of hepatology - 1 Jan 2000
Conti Fabio, Vukotic Ranka, Lorenzini Stefania, Riili Anna, Cursaro Carmela, Scuteri Alessandra, Loggi Elisabetta, Galli Silvia, Furlini Giuliano, Bernardi Mauro, Andreone Pietro
Abstract excerpt
BACKGROUND AND AIM: In patients with chronic hepatitis C receiving Peg interferon/ribavirin (PEG-IFN/RBV) who do not achieve ≥ 2 log-reduction in HCV-RNA at week 12 (null responders, NR) and in those with ≥ 2 log-decrease but detectable at week 24 (partial responders, PR) the probability to achieve the sustained virological response (SVR) is almost null. The aim of this study was to investigate the efficacy of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.